» Articles » PMID: 27031036

Risk of Miscarriage in Women Receiving Antidepressants in Early Pregnancy, Correcting for Induced Abortions

Overview
Journal Epidemiology
Specialty Public Health
Date 2016 Apr 1
PMID 27031036
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Earlier studies on the association between antidepressant use and miscarriage have obtained conflicting results after accounting for the role of depression, and none have taken into account the high risk of induced abortions in women using antidepressants.

Methods: We identified 41,964 pregnant women delivering between 1998 and 2002 using Quebec's health administration databases. We compared women prescribed antidepressants in the first trimester and with a recorded diagnosis of depression before pregnancy to (1) women with neither antidepressant use nor a depression diagnosis before or during pregnancy; (2) women with a depression diagnosis before pregnancy, but no antidepressants prescribed in the first trimester; and (3) women prescribed hypothyroid medication in the first trimester, but not antidepressants. We used log binomial regression to assess the adjusted relative risk of miscarriage, corrected for induced abortion risk.

Results: The miscarriage risk uncorrected for induced abortions was 16%, 10%, and 9% for depressed women exposed to antidepressants; unexposed depressed women; and unexposed, nondepressed women, respectively. These decreased to 11%, 8%, and 7% after correction for induced abortions. In multivariable analysis, the corrected risk of miscarriage relative to unexposed, nondepressed women was 1.3 (1.1-1.5) for antidepressant-exposed women and 1.1 (1.0-1.2) for unexposed depressed women. The miscarriage relative risk for antidepressant users compared with unexposed depressed women was thus 1.2 (1.0-1.4).

Conclusions: Antidepressant use in the first trimester is associated with an increased risk of miscarriage when compared with either nondepressed or depressed unexposed women, even after accounting for induced abortions.

Citing Articles

Contraception use and pregnancy in women receiving a 2-dose Ebola vaccine in Rwanda: A retrospective analysis of UMURINZI vaccination campaign data.

Ingabire R, Nyombayire J, Mazzei A, Mazarati J, Noben J, Katwere M PLoS Med. 2025; 22(2):e1004508.

PMID: 39932900 PMC: 11813098. DOI: 10.1371/journal.pmed.1004508.


Association of MTR and MTRR polymorphisms with recurrent pregnancy loss: a case control study.

Shaker M, Elaraby N, Shalabi T Mol Biol Rep. 2024; 51(1):971.

PMID: 39249145 DOI: 10.1007/s11033-024-09860-4.


Association between antidepressant use during pregnancy and miscarriage: a systematic review and meta-analysis.

Smith S, Martin F, Rai D, Forbes H BMJ Open. 2024; 14(1):e074600.

PMID: 38272551 PMC: 10824002. DOI: 10.1136/bmjopen-2023-074600.


Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Meta-Analysis of Pharmacotherapy.

Viswanathan M, Middleton J, Stuebe A, Berkman N, Goulding A, McLaurin-Jiang S Psychiatr Res Clin Pract. 2022; 3(3):123-140.

PMID: 36101835 PMC: 9175843. DOI: 10.1176/appi.prcp.20210001.


Pre-pregnancy lifestyle characteristics and risk of miscarriage: the Australian Longitudinal Study on Women's Health.

Magnus M, Hockey R, Haberg S, Mishra G BMC Pregnancy Childbirth. 2022; 22(1):169.

PMID: 35232386 PMC: 8887017. DOI: 10.1186/s12884-022-04482-9.